Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating

International Journal of Pharmaceutics

Volumn 336, Issue 1, 2007, Pages 82-89

  Hasegawa, Susumu ^a   Furuyama, Naho ^a   Yada, Shuichi ^a   Hamaura, Takeshi ^a   Kusai, Akira ^a   Yonemochi, Etsuo ^b   Terada, Katsuhide ^b  

^a DAIICHI SANKYO CO   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Interaction; Physical property; PVP; Solid dispersion; Troglitazone

Indexed keywords

POVIDONE; TROGLITAZONE;

ARTICLE; DRUG SOLUBILITY; HEATING; HYDROGEN BOND; INFRARED SPECTROSCOPY; MELTING POINT; MOLECULAR INTERACTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADHESIONS; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMANS; CHROMATOGRAPHY, GAS; CRYSTALLOGRAPHY; EXCIPIENTS; HEAT; HYDROGEN BONDING; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHASE TRANSITION; PLATELET AGGREGATION INHIBITORS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; THERMODYNAMICS; THIAZOLIDINEDIONES; TRANSITION TEMPERATURE; WATER; X-RAY DIFFRACTION;

EID: 34047275565     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.11.041     Document Type: Article

References (19)

1. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971) 1281-1302
2. Fujii M., Okada H., Shibata Y., Teramachi H., Kondoh M., and Watanabe Y. Preparation, characterization, and tableting of solid dispersion of indomethacin with crospovidone. Int. J. Pharm. 293 (2005) 145-153
3. Grimsey I.M., Feeley J.C., and York P. Analysis of the surface energy of pharmaceutical powders by inverse gas chromatography. J. Pharm. Sci. 91 (2002) 571-583
4. Hamaura T., and Newton J.M. Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol. J. Pharm. Sci. 88 (1999) 1228-1233
5. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
6. Hasegawa S., Hamaura T., Furuyama N., Horikawa S., Kusai A., Yonemochi E., and Terada K. Uniformity and physical states of troglitazone in solid dispersions determined by electron probe microanalysis and microthermal analysis. Int. J. Pharm. 280 (2004) 39-46
7. Hasegawa S., Hamaura T., Furuyama N., Kusai A., Yonemochi E., and Terada K. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 302 (2005) 103-112
8. *)-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazolidine monohydrate. Anal. Sci. 16 (2000) 443-444
9. *)-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, troglitazone dihydrate. Anal. Sci. 17 (2001) 467-468
10. Kobayashi K., Fukuhara H., Hata T., Sekine A., Uekusa H., and Ohashi Y. Physicochemical and crystal structure analyses of the antidiabetic agent troglitazone. Chem. Pharm. Bull. 51 (2001) 807-814
11. Lai M.C., Hageman M.J., Schowen R.L., Borchardt R.T., Laird B.B., and Topp E.M. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone). J. Pharm. Sci. 88 (1999) 1081-1089
12. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
13. Nardin M., and Papirer E. Relationship between vapor pressure and surface energy of liquids: application to inverse gas chromatography. J. Colloid Interf. Sci. 137 (1990) 534-545
14. Newell H.E., Buckton G., Butler D.A., Thielmann F., and Williams D.R. The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallization. Int. J. Pharm. 217 (2001) 45-56
15. Schultz J., Lavielle L., and Martin C. The role of the interface in carbon fibre-epoxy composites. J. Adhes. 23 (1987) 45-60
16. Serajuddin A.T. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
17. Suzuki N., Kasahara K., Hasegawa H., and Kawasaki T. Physical property of troglitazone, an equal mixture of four stereoisomers. Int. J. Pharm. 248 (2002) 71-80
18. Taylor L.S., and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
19. Vyas K., Sivalakshmidevi A., Prabhakar C., and Reddy G.O. Troglitazone, an euglycemic antidiabetic drug. Acta Crystallogr. C 55 (1999) 411-413